Thu.Nov 14, 2024

article thumbnail

A Genetic Crystal Ball: When Newborn Genome Sequencing Findings Explain Illnesses in Relatives

PLOS: DNA Science

In 2019, I wrote about how sequencing the genomes of newborns might compromise their privacy if genetic information was not adequately protected as they grew up. Now five years later, researchers are recognizing a perhaps unexpected benefit of newborn DNA analysis – explaining seemingly unrelated symptoms in relatives. Newborn Screening for Metabolites, not DNA Screening newborns for telltale molecules other than DNA has been around for decades.

DNA 97
article thumbnail

The Role of CROs in Generic Drug Development

Drug Patent Watch

The pharmaceutical industry has undergone significant transformations in recent years, with the increasing complexity of clinical trials and the need for cost and time efficiency driving the growth of contract research organizations (CROs).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CRISPR 101: Targeting Non-Coding RNAs with CRISPR/Cas9

addgene Blog

You’ve probably heard that only 2% of our genome is made of protein-coding genes, and you might be wondering what the rest of our genome could possibly be made up of. The answer is… drum roll please… non-coding RNAs! You probably didn’t see that coming, right? Non-coding RNAs (ncRNAs) are transcribed but do not encode proteins. They play important roles in many cellular and regulatory processes, but much of their functionality is yet to be unveiled as they are more difficult to functionally mani

75
article thumbnail

Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy

BioPharma Drive: Drug Pricing

The company is paying China-based biotech LaNova Medicines $588 million for the type of dual-pronged antibody drug that recently bested Keytruda in a clinical trial.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Scientists discover laser light can cast a shadow

Science Daily: Pharmacology News

Researchers have found that under certain conditions, a laser beam can act like an opaque object and cast a shadow, opening new possibilities for technologies that could use a laser beam to control another laser beam.

article thumbnail

Malaria Developing Resistance to Drug That Saves Children's Lives

Drugs.com

THURSDAY, Nov. 14, 2024 -- Over 600,000 people worldwide die from mosquito-borne malaria each year, with the majority of these deaths happening among children under 5.Now, there's troubling news that the malaria parasite may be gaining resistance.

Drugs 69

More Trending

article thumbnail

Anti-anxiety and hallucination-like effects of psychedelics mediated by distinct neural circuits

Science Daily: Pharmacology News

New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics. The anti-anxiety andhallucination-inducing qualities of psychedelic drugs work through different neural circuits, according to research using a mouse model.

article thumbnail

Gum Disease & Diabetes: A Strong Link

Drugs.com

THURSDAY, Nov. 14, 2024 -- Periodontal (gum) disease and diabetes are locked in a grim partnership aimed at undermining your health, experts warn.“Recent research has shown that diabetes is not only a major risk factor for periodontitis but that t.

Disease 59
article thumbnail

FDA and the Device Industry: Friends or Foes?

FDA Law Blog: Biosimilars

By Jennifer D. Newberger — “An open foe may prove a curse, but a pretended friend is worse.” When the poet John Gay wrote these words in 1727, the idea of an administrative agency like the FDA was likely the furthest thing from his mind. That he is now being quoted in a blog post to discuss the relationship between medical device companies and their regulatory oversight body shows that some ideas really do have staying power.

FDA 58
article thumbnail

New U.S. Overdose Death Numbers Show 'Sustained' Decline

Drugs.com

THURSDAY, Nov. 14, 2024 -- After decades of battling the opioid epidemic, U.S. health officials reported Wednesday that overdose deaths have now declined for the second year in a row.By how much did these deaths of despair drop? There were about.

59
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

MAHA, Nutrition, and the FDA

FDA Law Blog: Biosimilars

By Ricardo Carvajal — Among the more interesting developments in the recent election was the emergency of Robert Kennedy as a prominent figure in the MAGA movement – and the collateral emergence of the MAHA movement (Make America Healthy Again). As crisply laid out in short YouTube video , MAHA aims to transform public health by zeroing in on “our nation’s biggest health challenge – chronic disease.

FDA 58
article thumbnail

Don’t try to fit a Layout Builder peg in a Site Studio hole.

Perficient: Drug Development

How to ensure your toolset matches your vision, team and long term goals. Seems common sense right? Use the right tool for the right purpose. However, in the DXP and Drupal space, we often see folks trying to fit their project to the tool and not the tool to the project. There are many modules, profiles, and approaches to building Drupal out there, and most all of them have their time and place.

article thumbnail

The Power of Worldwide Networks in Data and Safety Monitoring Boards

Advarra

In an era where clinical trials are increasingly global, it’s more imperative than ever to leverage international expertise. Data and safety monitoring boards (DSMBs), also known as data monitoring committees (DMCs), play a critical role in overseeing a clinical trial’s safety and efficacy. These independent committees are entrusted with the task of safeguarding study participant’s interests while ensuring the trial’s scientific integrity.

article thumbnail

Challenges and Future Trends in Biomarker Analysis for Clinical Research: What’s Ahead in 2025

Crown Bioscience

As we approach 2025, biomarker analysis in the preclinical stage is poised for transformative changes, driven by advances in technology, data science, and evolving regulatory frameworks. These innovations promise to enhance the precision and efficacy of early-stage research, setting a solid foundation for subsequent clinical applications and enabling the development of more personalized medicine.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

AI Regulations for Financial Services: South Korea and the UK

Perficient: Drug Development

Artificial intelligence (AI) is poised to affect every aspect of the world economy and play a significant role in the global financial system, leading financial regulators around the world to take various steps to address the impact of AI on their areas of responsibility. The economic risks of AI to the financial systems include everything from the potential for consumer and institutional fraud to algorithmic discrimination and AI-enabled cybersecurity risks.

article thumbnail

Many Cases of Dementia Go Undiagnosed in Poorer Communities

Drugs.com

THURSDAY, Nov. 14, 2024 -- Dementia strikes all races, but new research suggests thinking declines in poor seniors are often overlooked.Among a group of more than 200 low-income patients who were treated at community health centers, 3 of 4 had.

article thumbnail

Introduction to State Handling Excellence in React- A Developer’s Perspective

Perficient: Drug Development

Handling an application’s state, or state management, plays an essential role in creating dynamic and responsive user interfaces and effectively executing business logic. React offers numerous state management methods for storing and updating data, making it a popular web development technology. Think of it like different ice cream flavors: some people like chocolate (Redux), some like vanilla (Recoil), and some like strawberry (MobX).

52
article thumbnail

Telling Your Doctor About a Health Issue Doesn't Mean It Enters Medical Record

Drugs.com

THURSDAY, Nov. 14, 2024 (HealthDay news) -- Don't think your doctor is always taking your health concerns seriously? You might be right.New research reveals that primary care physicians frequently won’t write down health issues raised by patients i.

Doctors 52
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Meet the Expert: Andrew Bright

thought leadership

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and highlight how our colleagues work together on our higher purpose to improve patient health and safety throughout the complete product lifecycle.

article thumbnail

New Therapeutic Vaccine Gives Hope Against an Aggressive Breast Cancer

Drugs.com

THURSDAY, Nov. 14, 2024 -- An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and effective against triple-negative.

Vaccine 52
article thumbnail

Key Strategies Central Labs Use to Fast-Track Time to Market

Reprocell

The journey of drug discovery is notoriously long; from initial discovery and development to clinical assessment and final approval, the process can take anywhere from 10 to 30 years and cost billions of dollars 1, 2. To address the issues of time and cost, pharmaceutical companies rely on central laboratories (CLs) for consistency, organization, and efficiency during the clinical trial phase, which is essential for drug approval.

article thumbnail

These Are the 3 Big Factors Driving Strokes

Drugs.com

THURSDAY, Nov. 14, 2024 -- A trio of risk factors not only increase your risk of stroke, but they also raise the odds that such a stroke will be debilitating, a new study warns.What are these three big dangers? Smoking, having high blood pressure.

52
article thumbnail

PTC wins US approval of gene therapy for fatal enzyme disorder

BioPharma Drive: Drug Pricing

Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review voucher for PTC.

article thumbnail

More Than 800 Million People Worldwide Now Have Diabetes

Drugs.com

THURSDAY, Nov. 14, 2024 -- Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the blood sugar disease since 1990, new statistics show.Type 2 diabetes, which makes up 95% of cases.

Disease 52
article thumbnail

Could a Consultant Accelerate Your Drug Product Development Timelines?

DS in Pharmatics

If you are searching for a way to accelerate your drug product development timelines, it is recommended you speak with a consultant. Discover why here!

article thumbnail

1 in 3 Surgery Patients Suffer Complications

Drugs.com

THURSDAY, Nov. 14, 2024 -- More than a third of surgical patients develop complications as a result of their procedure, a new study shows.About 38% of adult patients suffer an adverse event during or following their surgery, researchers reported.

article thumbnail

Trump names RFK Jr. as his pick to lead HHS

BioPharma Drive: Drug Pricing

If confirmed to the role, Robert F. Kennedy Jr. would oversee the country's top health agencies, including the Food and Drug Administration and the Centers for Disease Control and Prevention.

Disease 135
article thumbnail

E. Coli Illnesses Linked to McDonald's Quarter Pounders Climb to 104

Drugs.com

THURSDAY, Nov. 14, 2024 -- The number of Americans sickened in an E. coli outbreak tied to slivered onions used on McDonald's Quarter Pounders has now risen to 104, U.S. health officials reported Wednesday.In an update posted on its website, the.

52
article thumbnail

ICYMI, Txt Abbreviations Cn Make U Seem Insincere, Study Finds

Drugs.com

THURSDAY, Nov. 14, 2024 -- Using abbreviations while texting might save some typing time, but it won't make a good impression, a new study finds.People who use texting abbreviations like IDK or GOAT are perceived as more insincere and are less.

52